Sign In
Buy TRIB
$11.60
-1.15 (-9.02%)
At Close: Jul 31, 2026
Trinity Biotech Provides Business and Trading Update
07:45am, Tuesday, 10'th Mar 2026
DUBLIN, March 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearab
Critical Review: Trinity Biotech (NASDAQ:TRIB) vs. Ayr Wellness (OTCMKTS:AYRWF)
01:54am, Tuesday, 10'th Mar 2026
Ayr Wellness (OTCMKTS:AYRWF - Get Free Report) and Trinity Biotech (NASDAQ: TRIB - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based
Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
09:00am, Wednesday, 25'th Feb 2026
- Agreement provides additional funding tool of up to $25 million over a period of up to 36 months - Underpins the Company's ambitions to expand its commercialisation activities and advance its innova
DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearabl
DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearabl
DUBLIN, Ireland, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, includin
– Reinforces Trinity Biotech's growing position as a key player in diabetes care innovation – Senior commercial executives of Trinity Biotech are attending the World Health Expo from February 10-1
Trinity Biotech Stock Jumps 60% After Major Breakthrough
11:45am, Tuesday, 23'rd Dec 2025
Trinity Biotech (TRIB) shares rose about 60% on Tuesday following updates that improved the company's near- and long-term outlook.The diagnostics firm secured a
Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives
08:50am, Tuesday, 23'rd Dec 2025
- Arrangements provide increased near-term funding and extend maturity of credit agreement to early 2027 - Equity settlement mechanisms also agreed for milestone payments and contingent acquisitio
Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests
07:32am, Tuesday, 23'rd Dec 2025
- TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA 1 positive operations in Q3 2025 and expects to achieve strong a
Company advances its mission to deliver next-generation diabetes management solutions and expand global market penetration
Head to Head Contrast: Trinity Biotech (NASDAQ:TRIB) vs. Smith & Nephew SNATS (NYSE:SNN)
02:30am, Sunday, 07'th Dec 2025
Trinity Biotech (NASDAQ: TRIB - Get Free Report) and Smith and Nephew SNATS (NYSE: SNN - Get Free Report) are both medical companies, but which is the better investment? We will compare the two busine
Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, EBITDA Accretion and Cashflow Generation Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion,
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test
09:00am, Friday, 14'th Nov 2025
DUBLIN, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearabl
DUBLIN, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearabl
